Sales decline 5.74% to Rs 230.13 crore
Net profit of Elder Pharmaceuticals rose 7.71% to Rs 18.44 crore in the quarter ended March 2013 as against Rs 17.12 crore during the previous quarter ended March 2012. Sales declined 5.74% to Rs 230.13 crore in the quarter ended March 2013 as against Rs 244.14 crore during the previous quarter ended March 2012.For the Audited full year,net profit rose 3.33% to Rs 86.96 crore in the year ended March 2013 as against Rs 84.16 crore during the previous year ended March 2012. Sales rose 6.08% to Rs 1042.00 crore in the year ended March 2013 as against Rs 982.24 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales230.13244.14 -6 1042.00982.24 6 OPM %17.4619.30 -10 20.2720.58 -2 PBDT30.4727.43 11 143.23137.44 4 PBT23.1923.57 -2 114.05109.80 4 NP18.4417.12 8 86.9684.16 3
Powered by Capital Market - Live News